The absence of ALG9 in the ADPKD patient’s cyst wall lining suggests that the progression of liver cyst growth in ADPLD patients is different than in ADPKD patients, and that this progression in ADPLD is due to a molecular mechanism that requires high levels of ALG9. This evidence concerns the gene ALG9 and Hepatic cysts.